Danske Bank share buy-back programme: transactions in week 8

Seeking Alpha / 1 hour from now 1 Views

Attachment

MPLAB® XC Unified Compiler Licenses Deliver Streamlined Software Management

4 hours from now
Volaris Reports Financial Results for the Fourth Quarter 2024: Net Income of $46 million

4 hours from now
FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing

4 hours from now
FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing

4 hours from now
FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing

4 hours from now